Christian Kassasseya

Christian Kassasseya

Auto-generated profile, based on publicly available information

Christian Kassasseya

Emergency Department, Hôpital Henri, Mondor, Assistance Publique - Hôpitaux de Paris, Créteil, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in Annals of Internal Medicine
Verified
Journal Article
Open access
DBDonia Bouzid
Donia Bouzid
BVBenoit Visseaux
Benoit Visseaux
CKChristian Kassasseya
Christian Kassasseya
ADAsma Daoud
Asma Daoud
FFFlorent Fémy
Florent Fémy
IGIMProving Emergency Care (IMPEC) FHU Collaborators Group*
IMProving Emergency Care (IMPEC) FHU Collaborators Group*
At the end of 2021, infections with the B.1.1.529 SARS-CoV-2 variant (Omicron) superseded those with the B.1.617.2 variant (Delta). This study compares baseline characteristics and in-hospital outc... Visual Patients With Delta Versus Omicron Variants in the Emergency Department. At the end of 2021, infections with the B.1.1.529 SARS-CoV-2 variant (Omicron) superseded those with the B.1... Background: At the end of 2021, the B.1.1.529 SARS-CoV-2 variant (Omicron) wave superseded the B.1.617.2 variant (Delta) wave. Objective: To compare baseline characteristics and in-hospital outcome...

1 November 2023 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
IBIsaure de Boisriou
Isaure de Boisriou
SESami Ellouze
Sami Ellouze
CKChristian Kassasseya
Christian Kassasseya
AFAnne Laure Féral-Pierssens
Anne Laure Féral-Pierssens
CGCamille Gerlier
Camille Gerlier
OPOlivier Peyrony
Olivier Peyrony

28 January 2026 in American Journal of Hematology
Verified
Journal Article
Closed access
WLWeiqiang Liu
Weiqiang Liu
CKChristian Kassasseya
Christian Kassasseya
LPLazaros Papamanolis
Lazaros Papamanolis
KNKim‐Anh Nguyen‐Peyre
Kim‐Anh Nguyen‐Peyre
MGMorgane Garreau
Morgane Garreau
IVIrene Vignon‐Clementel
Irene Vignon‐Clementel

4 March 2021 in Academic Emergency Medicine
Verified
Journal Article
Open access
PDF file
MRMelanie Roussel
Melanie Roussel
ACAnthony CHAUVIN
Anthony CHAUVIN
PBPierrick Le Borgne
Pierrick Le Borgne
MDMarie Drogrey
Marie Drogrey
XEXavier Eyer
Xavier Eyer
YFYonathan Freund
Yonathan Freund
Introduction Seizures are one of the most common neurological reasons for emergency department (ED) visits. The benefit of ED‐initiated, short‐course outpatient benzodiazepine (BZD) treatment to prevent early recurrent seizure is unknown. This study assesses the risk of early seizure recurrence in patients who were or were not started with outpatient BZD in the ED. Methods This was a multicenter retrospective study conducted in eight French EDs between January 1 and December 31, 2019. All patients admitted for seizure were retrospectively screened and those discharged home from the ED were included. Patients with a history of chronic alcohol intoxication or chronic BZD therapy were excluded. Baseline characteristics, type of seizure, and 30‐day outcome were retrospectively collected from the electronic health records. The primary endpoint was a return visit for seizure recurrence within 30 days. Independent factors associated with a seizure recurrence were identified using a multivariable binary logistic regression. Results A total of 2,218 patients were included and 1,820 were analyzed. The median age was 39 years and 60% were men. Among them 82% of patients had a generalized tonic–clonic seizure and 47% of seizures were idiopathic. BZD treatment was started in 773 (42%) patients. A total of 154 (8%) patients had an early recurrence at 30 days: 68 (9%) in patients who were treated with BZD versus 86 (8%) in patients who were not (odds ratio [OR] = 1.07, 95% confidence interval [CI] = 0.71 to 1.43). In multivariable analysis, two factors were independently associated with the primary endpoint: chronic epileptic treatment (adjusted OR = 2.58, 95% CI = 1.55 to 4.37) and having had a focal seizure (adjusted OR = 2.16, 95% CI = 1.56 to 4.37). Conclusion BZD therapy was started in 42% of patients who were discharged home after ED visit for a seizure. This treatment was not an independent factor associated with the risk of return visit for seizure recurrence at 30 days.

8 April 2026 in Clinical and Experimental Emergency Medicine
Verified
Journal Article
Open access
PDF file
TRThomas Roudaut
Thomas Roudaut
MCMoussa Camara
Moussa Camara
CKChristian Kassasseya
Christian Kassasseya
Clinical and Experimental Emergency Medicine

1 July 2022 in Annales françaises de médecine d'urgence
Verified
Journal Article
Closed access
PDF file
CKC. Kassasseya
C. Kassasseya
SBS. Bressand
S. Bressand
MKM. Khellaf
M. Khellaf
La drépanocytose est aujourd’hui la première maladie génétique en France avec environ 30 000 patients adultes. Une mutation ponctuelle sur le chromosome 11 conduit à la production d’une hémoglobine pathologique qui polymérise sous l’effet de facteurs endo-ou exogènes induisant la falciformation des globules rouges à l’origine d’une vasoocclusion artérielle dont une des conséquences est l’oblitération des vaisseaux à destinée osseuse. Les infarctus osseux sont particulièrement douloureux, conduisant les patients aux urgences où l’enjeu est de soulager rapidement les douleurs par l’utilisation de morphine principalement par analgésie autocontrôlée après titration morphinique. Le risque majeur au cours de ces crises vaso-occlusives (CVO) est l’apparition d’un syndrome thoracique aigu (STA) pouvant mettre en jeu le pronostic vital du patient. La spirométrie incitative est un moyen préventif du STA important à instituer dès les urgences. Une antibiothérapie sera mise en place en cas de fièvre chez ces patients aspléniques à risque d’infections à germes encapsulés notamment par le pneumocoque. L’échange transfusionnel est une des pierres angulaires du traitement des CVO ou du STA mais le risque d’accident hémolytique aigu post transfusionnel doit en limiter l’usage à des situations mettant en jeu le pronostic vital ou fonctionnel d’organe. Plusieurs scores clinicobiologiques permettent de décider de l’utilité d’un angioscanner thoracique au cours du STA à la recherche d’une embolie pulmonaire ou pour décider de la pertinence d’une sortie vers une hospitalisation à domicile (Programme DREPADOM). L’utilisation de la morphine en dehors de l’hôpital de façon prolongée doit être prudente en raison du risque d’addiction.